Clinical trials
Completed Phase 1 Breast Neoplasms, Male trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 8 |
| 2002 | 3 |
| 2003 | 5 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 5 |
| 2008 | 1 |
| 2010 | 8 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 58 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 17 |
| Memorial Sloan Kettering Cancer Center | 3 |
| Case Comprehensive Cancer Center | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| H. Lee Moffitt Cancer Center and Research Institute | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
| National Institutes of Health Clinical Center (CC) | 2 |
| University of Arizona | 2 |
| University of Chicago | 2 |
| Vanderbilt-Ingram Cancer Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 58 |
| Breast Neoplasms, Male | 58 |
| Carcinoma, Non-Small-Cell Lung | 19 |
| Carcinoma, Ovarian Epithelial | 18 |
| Colonic Neoplasms | 17 |
| Rectal Neoplasms | 15 |
| Carcinoma, Renal Cell | 14 |
| Pancreatic Neoplasms | 14 |
| Carcinoma, Hepatocellular | 12 |
| Prostatic Neoplasms | 12 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.